|
|
News Breaks
|
October 26, 2009
|
| 08:54 EDT |  | PLX |
| theflyonthewall.com: | Protalix volatility at 107 | | Protalix, a biopharmaceutical company, closed at $8.44. PLX over all option implied volatility of 101 is near it's near its 8-week average of 107 according to Track Data, suggesting non-directional price movement. :theflyonthewall.com |
|
|
News For PLX From The Last 14 Days Check below for free stories on PLX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 05:49 EDT |  | PLX |
| theflyonthewall.com: | Protalix says taliglucerase alfa extension trial statistically significant | | Protalix BioTherapeutics announced that new clinical data on taliglucerase alfa will be presented at the Lysosomal Disease Network: WORLD Symposium 2012 being held February 8-10 in San Diego, California. Patients treated with taliglucerase alfa in the extension trial continued to demonstrate a statistically significant reduction in mean spleen volume after 24 months, compared with baseline, in both treatment groups. Statistically significant improvements were also observed in all secondary end points, the company said. Both groups demonstrated statistically significant mean reductions in liver volume. :theflyonthewall.com |
|
|
|
|
|
